Search Results 3191-3200 of 19750 for celiac disease

1. Biomarker Serum Biobank for Glomerular Disease - Mayo Clinic

   ... disease, immunoglobulin- and complement-mediated glomerular disease, and ANCA vasculitis. Serum (up to 10 ml) will be obtained within two weeks of renal ...

2. Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. News - Allison C. Rosenthal, D.O. - Mayo Clinic

   Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and ...

4. Familial adenomatous polyposis - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are continually developing improved screening methods and treatments for hereditary polyp disorders, such as FAP, and colorectal cancer.

5. Familial adenomatous polyposis - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are continually developing improved screening methods and treatments for hereditary polyp disorders, such as FAP, and colorectal cancer.

6. Familial adenomatous polyposis - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are continually developing improved screening methods and treatments for hereditary polyp disorders, such as FAP, and colorectal cancer.

7. TMJ disorders - Doctors and departments - Mayo Clinic

   Treatment options for pain in your jaw joint and in the muscles that control jaw movement can include pain management, medical therapies and surgery.

8. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

   ... and ZX008-1502). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

9. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   Renal impairment is a major complication of multiple myeloma (MM) and majority of MM participants either are at risk or already have renal dysfunction at ...

10. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

    Giving binimetinib and encorafenib may work better compared to the usual treatment in treating patients with pancreatic cancer and a somatic BRAF V600E mutation ...